PortfoliosLab logoPortfoliosLab logo

Highlights

Avg. Volume (1M)
0
Avg. Volume Value (1M)
$0.00

Share Price Chart


Loading charts...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


ARCA Pharmaceutical Index

Often compared with ^DRG:
^DRG vs. BRK-A

Performance

^DRG Performance Chart

ARCA Pharmaceutical Index (^DRG) is up 8.9% since the beginning of the year. ^DRG is currently trading at $1,227 per share. Investors who bought $1,000 worth of ^DRG shares 5 years ago would now be looking at an investment worth $1,597.


Loading charts...

Benchmark

Compare this symbol against anything

Returns By Period

ARCA Pharmaceutical Index (^DRG) has returned 8.93% so far this year and 35.32% over the past 12 months. Over the last ten years, ^DRG has returned 8.33% per year, falling short of the S&P 500 Index benchmark, which averaged 13.26% annually.


ARCA Pharmaceutical Index

1D
-0.95%
1M
-3.33%
6M
6.16%
YTD
8.93%
1Y
35.32%
3Y*
12.09%
5Y*
9.82%
10Y*
8.33%
ALL TIME*
8.69%

Benchmark (S&P 500 Index)

1D
0.70%
1M
0.09%
6M
7.94%
YTD
9.41%
1Y
20.07%
3Y*
17.84%
5Y*
11.25%
10Y*
13.26%
ALL TIME*
8.09%
*Multi-year figures are annualized to reflect compound growth (CAGR)

^DRG Monthly Returns History

Based on dividend-adjusted daily data since Feb 22, 1994, ^DRG's average daily return is +0.04%, while the average monthly return is +0.79%. At this rate, an investment would double in approximately 7.3 years.

Historically, 59% of months were positive and 41% were negative. The best month was Oct 1999 with a return of +13.7%, while the worst month was Feb 2009 at -12.3%. The longest winning streak lasted 13 consecutive months, and the longest losing streak was 7 months.

On a daily basis, ^DRG closed higher 52% of trading days. The best single day was Oct 13, 2008 with a return of +10.6%, while the worst single day was Aug 31, 1998 at -8.4%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20262.61%4.66%-6.35%-2.24%4.73%6.97%-1.11%8.93%
20253.77%6.88%-5.11%-1.01%-5.71%0.76%-3.98%7.13%2.40%2.61%11.65%0.90%20.51%
20244.91%5.14%2.22%-2.74%3.07%3.23%-1.25%8.71%-5.43%-4.65%-4.22%-5.12%2.66%
2023-3.60%-3.91%4.67%4.09%-3.35%3.23%0.19%3.45%-2.58%-2.99%3.50%2.72%4.87%
2022-3.59%-1.55%6.25%-0.51%1.81%-1.07%-0.98%-8.56%-2.03%8.54%7.26%0.53%4.91%
20211.39%-2.58%1.81%1.58%3.15%2.33%3.27%2.52%-6.37%5.58%-2.68%9.23%19.99%

Benchmark Metrics

ARCA Pharmaceutical Index has an annualized alpha of 3.05%, beta of 0.68, and R2 of 0.48 versus S&P 500 Index. Calculated based on daily prices since February 22, 1994.

  • This index participates in less of S&P 500 Index's moves in both directions, but captures a larger share of gains (69.28%) than losses (65.80%) - typical of diversified or defensive assets.
  • Beta of 0.68 may look defensive, but with R2 of 0.48 this index is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this index's risk.
  • R2 of 0.48 means the benchmark explains less than half of this index's behavior - treat beta with caution or consider switching to a more representative benchmark.

Alpha
3.05%
Beta
0.68
0.48
Upside Capture
69.28%
Downside Capture
65.80%

Return for Risk

Risk / Return Rank

^DRG ranks 88 for risk / return — above 88% of indices peers on PortfoliosLab. Its historical combined result is among the stronger results in the peer group.


^DRG Risk / Return Rank: 8888
Overall Rank
^DRG Sharpe Ratio Rank: 8686
Sharpe Ratio Rank
^DRG Sortino Ratio Rank: 9494
Sortino Ratio Rank
^DRG Omega Ratio Rank: 8989
Omega Ratio Rank
^DRG Calmar Ratio Rank: 8888
Calmar Ratio Rank
^DRG Martin Ratio Rank: 8282
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

Risk / Return Metrics

The table below present risk-adjusted performance metrics for ARCA Pharmaceutical Index (^DRG) and compare them to S&P 500 Index.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


^DRGBenchmarkDifference
Sharpe ratioReturn per unit of total volatility

+0.55

Sortino ratioReturn per unit of downside risk

+1.06

Omega ratioGain probability vs. loss probability

1.34

1.25

+0.09

Calmar ratioReturn relative to maximum drawdown

3.26

2.00

+1.26

Martin ratioReturn relative to average drawdown

9.17

8.49

+0.68

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the ARCA Pharmaceutical Index. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the ARCA Pharmaceutical Index was 51.48%, occurring on Mar 3, 2009. Recovery took 1172 trading sessions.

The current ARCA Pharmaceutical Index drawdown is 3.66%.


Drawdown

Fall

Recovery

Underwater

Related event

-51.48%Mar 2009
8y 3mo4y 7mo
12y 11moNov 2000 - Oct 2013
Financial crisis2007–2009
-31.21%Mar 2000
10mo 29d4mo 6d
1y 3moApr 1999 - Jul 2000
Dot-com crash2000–2002
-26.25%Mar 2020
2mo 2d3mo 26d
5mo 28dJan 2020 - Jul 2020
COVID crash2020
-24.50%Apr 2025
7mo 9d9mo 2d
1y 4moSep 2024 - Jan 2026
2025 selloff2025
-23.46%Dec 2016
1y 3mo1y 12mo
3y 3moAug 2015 - Nov 2018

Drawdown Indicators


^DRGBenchmarkDifference

Max Drawdown

Largest peak-to-trough decline

-51.48%

-56.78%

+5.30%

Max Drawdown (1Y)

Largest decline over 1 year

-11.74%

-9.10%

-2.64%

Max Drawdown (3Y)

Largest decline over 3 years

-24.50%

-18.90%

-5.60%

Max Drawdown (5Y)

Largest decline over 5 years

-24.50%

-25.43%

+0.93%

Max Drawdown (10Y)

Largest decline over 10 years

-26.25%

-33.92%

+7.67%

Current Drawdown

Current decline from peak

-3.66%

-1.58%

-2.08%

Average Drawdown

Average peak-to-trough decline

-14.16%

-10.70%

-3.46%

Ulcer Index

Depth and duration of drawdowns from previous peaks

4.17%

2.14%

+2.03%

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Portfolio Analyzer

Build a portfolio with ^DRG

Add ARCA Pharmaceutical Index to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with ^DRG